Abstract

AbstractPhotoaffinity labeling is a powerful technique to interrogate drug‐protein interactions in native cellular environments. Photo‐cross‐linkers are instrumental for this technique. However, the introduction of unnatural photo‐cross‐linkers may significantly reduce the bioactivity of the drug, thus impairing the chemoproteomic outcomes. Herein, we developed a common pharmacophore, isoxazole, into a natively embedded photo‐cross‐linker for chemoproteomics, which minimally perturbs the drug structure. The photo‐cross‐linking reactions of the isoxazole were thoroughly investigated for the first time. Functionalized isoxazoles were then designed and applied to protein labeling, demonstrating the superior photo‐cross‐linking efficiency. Subsequently, two isoxazole‐based drugs, Danazol and Luminespib, were employed in chemoproteomic studies, revealing their potential cellular targets. These results provide valuable strategies for future chemoproteomic study and drug development.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.